Down syndrome and other hereditary diseases

Home Efficacy of amino acids for treatment of neurological disease Down syndrome and other hereditary diseases

Down syndrome and other hereditary diseases

Experience with the use of amino acid compounds has shown the good pronounced results for the following most common hereditary diseases in our center:

  • Down syndrome;
  • Angelman syndrome;
  • Fragile X-chromosome syndrome;
  • Rett syndrome.

Our long-term experience in administration of amino acids in infants with Down syndrome shows well pronounced results in all cases. Children with Down syndrome improve in speech, cognitive function, physical developments and social behavior.In many cases the typical face features of this group of infants who have received amino acids become less expressed.

All children who received amino acids in the long-term do well attending neighborhood schools alongside peers who don't have Down syndrome.

Individuals with Down syndrome differ considerably in their language and communication skills. Some of the infants with Down syndrome could develop mild speech and mental retardation, whilst some of them could have severe forms of mental and speech retardation (some of them never learn to speak). Getting amino acid treatment early – often when they are just babies – can lead to healthier, happier and more independent lives. The children treated with amino acids usually attend schools, do well alongside other children, do sports, develop well physically and some of them have only slight, unapparent features of a Down syndrome person.

In cases of children with Angelman syndrome, administration of amino acids reduces seizures occurrence, muscle hypotony and ataxy, improves fine motoric and they start to appear interested in the surrounding environment. 

In cases of children with Rett’s syndrome, there was a reduction in the frequency of epileptic attacks, ataxia and an increased interest in the surrounding environment.
Anna Rett's syndrome -

Anna Rett syndrome

Children with fragile X-chromosome syndrome who receive amino acid treatment, clearly show a reduction in hyperactivity, improved concentration and attention and also of fine motoric and cognitive abilities.

In cases of children with Rett’s syndrome, there was a reduction in the frequency of epileptic attacks, ataxia and an increased interest in the surrounding environment.

The clinical image of Down syndrome and majority of hereditary diseases includes diverse neurological symptoms and mental and speech retardation. The type and severity of motor development disorders may vary from minimal motor insufficiency up to serious forms of cerebral palsy, and speech and intellectual – from minimal psycho – speech insufficiency up to serious forms of mental retardation, oligophrenia, dysphasia and disartria. In relation to communicative development – from insignificant specific features of behavior up to heavy forms of infantile autism.

Consultations:

Germanyde

Down syndrome and other hereditary diseases

Experience with the use of amino acid compounds has shown the good pronounced results for the following most common hereditary diseases in our center:

  • Down syndrome;
  • Angelman syndrome;
  • Fragile X-chromosome syndrome;
  • Rett syndrome.

Our long-term experience in administration of amino acids in infants with Down syndrome shows well pronounced results in all cases. Children with Down syndrome improve in speech, cognitive function, physical developments and social behavior.In many cases the typical face features of this group of infants who have received amino acids become less expressed.

All children who received amino acids in the long-term do well attending neighborhood schools alongside peers who don't have Down syndrome.

Individuals with Down syndrome differ considerably in their language and communication skills. Some of the infants with Down syndrome could develop mild speech and mental retardation, whilst some of them could have severe forms of mental and speech retardation (some of them never learn to speak). Getting amino acid treatment early – often when they are just babies – can lead to healthier, happier and more independent lives. The children treated with amino acids usually attend schools, do well alongside other children, do sports, develop well physically and some of them have only slight, unapparent features of a Down syndrome person.

In cases of children with Angelman syndrome, administration of amino acids reduces seizures occurrence, muscle hypotony and ataxy, improves fine motoric and they start to appear interested in the surrounding environment. 

In cases of children with Rett’s syndrome, there was a reduction in the frequency of epileptic attacks, ataxia and an increased interest in the surrounding environment.
Anna Rett's syndrome -

Anna Rett syndrome

Children with fragile X-chromosome syndrome who receive amino acid treatment, clearly show a reduction in hyperactivity, improved concentration and attention and also of fine motoric and cognitive abilities.

In cases of children with Rett’s syndrome, there was a reduction in the frequency of epileptic attacks, ataxia and an increased interest in the surrounding environment.

The clinical image of Down syndrome and majority of hereditary diseases includes diverse neurological symptoms and mental and speech retardation. The type and severity of motor development disorders may vary from minimal motor insufficiency up to serious forms of cerebral palsy, and speech and intellectual – from minimal psycho – speech insufficiency up to serious forms of mental retardation, oligophrenia, dysphasia and disartria. In relation to communicative development – from insignificant specific features of behavior up to heavy forms of infantile autism.

Online consultation
  • Convenient for patient
  • No need to travel, save time, money
  • With our doctor you could decide whether our amino acids treatment is suitable for you
  • You could order our amino acids to be send to you
Make an appointment First consultation is for free

Enrollment for consultation

Tel: (00420) 251 562 322
Fax: (00420) 251 563 320